Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
217.5 USD | +1.87% | +4.12% | -15.94% |
May. 03 | HSBC Adjusts Price Target on Biogen to $342 From $339, Maintains Buy Rating | MT |
Apr. 30 | Wall Street: buoyed by Tesla, confident ahead of FOMC meeting | CF |
ETFs positioned on Biogen Inc.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.30% | 1 M€ | -4.80% | - | |
3.92% | 0 M€ | 0.00% | - | |
3.75% | 0 M€ | 0.00% | - | |
2.39% | 14,021 M€ | +3.99% | ||
2.28% | 4 M€ | +20.15% | ||
1.91% | 6 M€ | +16.84% | - | |
1.78% | 115 M€ | +6.31% | - | |
1.69% | 2 M€ | +6.77% | ||
1.60% | 8 M€ | -.--% | ||
1.33% | 1,182 M€ | +1.22% | ||
1.30% | 9 M€ | -4.31% | - | |
1.00% | 16 M€ | -4.51% | ||
0.99% | 18 M€ | +3.01% | - | |
0.97% | 13 M€ | -.--% | - | |
0.97% | 3 M€ | +7.32% | - | |
0.97% | 1 M€ | +11.94% | - | |
0.94% | 204 M€ | +10.54% | ||
0.65% | 2 M€ | -25.75% | ||
0.64% | 8 M€ | +5.48% | - | |
0.48% | 4,592 M€ | +11.18% | ||
0.44% | 1 M€ | +16.32% | ||
0.43% | 26 M€ | +16.85% | - | |
0.38% | 2 M€ | +20.44% | - | |
0.38% | 22 M€ | 0.00% | - | |
0.37% | 5 M€ | -72.95% | - | |
0.37% | 9 M€ | -.--% | - | |
0.36% | 3 M€ | 0.00% | - | |
0.29% | 92 M€ | +0.06% | - | |
0.29% | 469 M€ | -2.05% | - | |
0.29% | 3,859 M€ | +18.82% | - | |
0.21% | 8 M€ | +3.61% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.94% | 31.67B | |
-3.79% | 88.14B | |
+1.45% | 40.51B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-9.12% | 11.97B | |
-14.38% | 12.07B | |
-42.56% | 11.61B | |
+4.87% | 8.81B | |
-4.33% | 8.5B |
- Stock Market
- Equities
- BIIB Stock
- Funds and ETFs Biogen Inc.